Organogenesis Holdings Inc. ( ORGO) - Key Metrics
ORGO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $1.78 | $0.34 | $0.31 | $0.27 |
| 2025Q3 | $1.19 | $0.17 | $0.02 | $0.01 |
| 2025Q2 | $0.79 | -$0.07 | -$0.26 | -$0.29 |
| 2025Q1 | $0.69 | -$0.15 | -$0.16 | -$0.19 |
ORGO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 0.43% | 3.76 |
| 2025Q3 | 38.71% | 6.21 |
| 2025Q2 | -29.92% | -12.36 |
| 2025Q1 | -12.73% | -7.24 |
ORGO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 5.94% | ? |
| 2025Q4 | 5.29% | 0.03% |
| 2025Q3 | 0.16% | 1.05% |
| 2025Q2 | -7.86% | 0.61% |
| 2025Q1 | -4.32% | 0.50% |
ORGO
Price: $2.48
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.12 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 317113
Market Capitalization: 288.2 million